Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 30, 2024DiabetologiaOpen Access

Activation of the hypoxia-inducible factor pathway by roxadustat improves glucose metabolism in human primary myotubes from men

View Full Paper
Ask AI
Bookmark
Share

Authors

SMSelina MäkinenSSSreesha SreeTATuulia Ala‐Nisula

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Mäkinen et al. (2024) studied this question.

synapsesocial.com/papers/68e67a85b6db643587603fd7https://doi.org/10.1007/s00125-024-06185-6
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Roxadustat enhances inflammation and metabolic reprogramming in human leukocytes by affecting oxygen sensing.2025
  2. 2Effect of Roxadustat on Cardiometabolism in Healthy Individuals (ROXACardioMeta): Protocol for a Double-Blind, Placebo-Controlled and Randomised Cross-Over Trial2026
  3. 3Clinically approved HIF-PHIs modulate redox metabolism, cell growth, and angiogenesis independent of HIF-1α/HIF-2α2026
  4. 4Exploring the potential application of roxadustat in chronic kidney disease-related osteoporosis based on the regulatory role of HIF-1α in bone metabolism.2026
  5. 5Roxadustat improves diabetic myocardial injury by upregulating HIF-1α/UCP2 against oxidative stress2025 · 20 citations